HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Bisaillon Selected Research

Antiviral Agents (Antivirals)

3/2005Iron inactivates the RNA polymerase NS5B and suppresses subgenomic replication of hepatitis C Virus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin Bisaillon Research Topics

Disease

6Infections
01/2023 - 12/2003
4Neoplasms (Cancer)
11/2019 - 01/2015
3Virus Diseases (Viral Diseases)
12/2022 - 08/2005
2Hepatocellular Carcinoma (Hepatoma)
05/2019 - 07/2007
1Colorectal Neoplasms (Colorectal Cancer)
11/2019
1Adenocarcinoma
01/2017
1Stomach Neoplasms (Stomach Cancer)
01/2017
1Human Influenza (Influenza)
01/2011
1Chronic Hepatitis C
03/2005

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2017
5RNA (Ribonucleic Acid)IBA
05/2019 - 12/2003
2ProteomeIBA
01/2023 - 01/2016
2Viral ProteinsIBA
12/2022 - 01/2019
2U5 Small Nuclear RibonucleoproteinIBA
12/2022 - 01/2022
2IronIBA
07/2007 - 03/2005
2Ribavirin (Virazole)FDA LinkGeneric
08/2005 - 12/2003
1InterferonsIBA
12/2022
1LigandsIBA
11/2019
1Protein Isoforms (Isoforms)IBA
11/2019
1BCL2-associated athanogene 1 proteinIBA
11/2019
1Messenger RNA (mRNA)IBA
11/2019
1CytochromesIBA
05/2019
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
05/2019
1Biomarkers (Surrogate Marker)IBA
05/2019
1Oncogene Proteins (Oncogene Protein)IBA
01/2019
15' Untranslated Regions (5' UTR)IBA
01/2015
1Histones (Histone)IBA
01/2015
1Nucleic AcidsIBA
01/2011
1Subgenomic RNAIBA
07/2007
1GuanosineIBA
08/2005
1Antiviral Agents (Antivirals)IBA
03/2005
1Interferon-alpha (Interferon Alfa)IBA
12/2003
1DNA-Directed RNA Polymerases (RNA Polymerase)IBA
12/2003